Skip to main content

Table 1 Availability of anti-malarials and malaria blood testing, among anti-malarial stockists

From: The malaria testing and treatment landscape in the southern Lao People’s Democratic Republic (PDR)

  Public health facility Community health worker Public sector total Private for-profit facility Pharmacy General retailer Private sector total
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
Proportion of outlets stocking: N = 91 N = 145 N = 236 N = 56 N = 309 N = 23 N = 394
Any national first-line ACT (AL) 99.5
(97.1, 99.9)
83.1
(72.3, 90.3)
88.8
(82.0, 93.2)
63.3
(45.8, 77.9)
51.7
(40.0, 63.2)
3.1
(0.5, 17.0)
40.8
(31.1, 51.2)
Chloroquine 4.6
(1.9, 10.6)
19.2
(11.2, 31.0)
14.1
(8.9, 21.7)
49.3
(33.7, 65.0)
74.6
(67.0, 80.9)
96.9
(83.0, 99.5)
77.6
(71.2, 83.0)
Primaquine 6.7
(1.57, 24.17)
0.0
2.8
(0.6, 12.13)
0.0
0.0
0.0
0.0
Oral artemisinin monotherapy 0.0
0.0
0.0
2.7
(0.5, 14.5)
0.0
0.0
0.3
(0.0, 1.6)
  N = 91 N = 154 N = 255 N = 58 N = 327 N = 30 N = 424
Any malaria blood testing 90.8
(77.4, 96.6)
78.4
(66.7, 86.9)
82.4
(74.2, 88.3)
77.0
(64.3, 86.2)
55.7
(44.2, 66.7)
6.1
(1.6, 20.6)
43.5
(34.2, 53.3)
Malaria microscopy 23.1
(14.9, 34.0)
0.0
7.3
(4.6, 11.4)
16.0
(9.4, 25.8)
0.3
(0.0, 1.7)
0.0
1.7
(1.0, 2.9)
Rapid diagnostic tests 85.4
(73.5, 92.5)
78.4
(66.7, 86.9)
80.6
(72.3, 86.9)
77.0
(64.3, 86.2)
55.7
(44.2, 66.7)
6.1
(1.6, 20.6)
43.5
(34.2, 53.3)
  1. AL artemether–lumefantrine